Terns Pharmaceuticals (TERN) Earnings Date & Reports
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TERN is expected to report earnings to rise 16.42% to -30 cents per share on November 18
Q3'25
Est.
$-0.30
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.04
The last earnings report on August 05 showed earnings per share of -25 cents, beating the estimate of -29 cents. With 1.18M shares outstanding, the current market capitalization sits at 492.59M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TERN showed earnings on August 05, 2025. You can read more about the earnings report here.